Search Results for "days"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for days. Results 21 to 30 of 1849 total matches.
Comparison Table: Drugs for Alzheimer's Disease (online only)
The Medical Letter on Drugs and Therapeutics • Aug 22, 2022 (Issue 1657)
)
5, 10, 23 mg tabs
$3.00
506.10
5 mg PO once/day in the evening;
after 4-6 wks can increase ...
View the Comparison Table: Drugs for Alzheimer's Disease
Expanded Table: Drugs for Malaria Prophylaxis (online only)
The Medical Letter on Drugs and Therapeutics • Jul 01, 2019 (Issue 1575)
Pediatric
1 adult tab (250/100 mg)
once/day
5-8 kg: ½ ped tab/day (1 ped
tab is 62.5/25 mg)
9-10 kg ...
View the Expanded Table: Drugs for Prophylaxis of Malaria
Drugs for Acute Otitis Media in Children
The Medical Letter on Drugs and Therapeutics • Feb 07, 2022 (Issue 1643)
complications, but
even without effective antibiotic treatment, severe
symptoms generally last only a few days ...
More antibiotics are prescribed for treatment of acute
otitis media (AOM) than for any other infection in
young children. Children with AOM typically present
with otalgia, fever, and bulging and erythema of the
tympanic membrane.
Betrixaban (Bevyxxa) for VTE Prophylaxis in Acute Medical Illness
The Medical Letter on Drugs and Therapeutics • Jan 01, 2018 (Issue 1537)
were expected to be hospitalized
for ≥3 days and moderately or severely immobilized
for ≥24 hours ...
The FDA has approved betrixaban (Bevyxxa –
Portola), a once-daily, oral, direct factor Xa inhibitor,
for prophylaxis of venous thromboembolism (VTE)
in adults hospitalized for an acute medical illness
who have moderately or severely restricted mobility
and other risk factors for VTE. Betrixaban is the
first oral anticoagulant to be approved in the US for
this indication.
Zuranolone (Zurzuvae) – An Oral Drug for Postpartum Depression
The Medical Letter on Drugs and Therapeutics • Dec 25, 2023 (Issue 1692)
for
treatment of postpartum depression (PPD).
Efficacy: One 14-day treatment cycle reduced depressive
symptoms ...
The FDA has approved the oral GABAA receptor
modulator zuranolone (Zurzuvae – Sage Therapeutics/Biogen) for treatment of postpartum depression
(PPD). Zuranolone is the second drug to be approved
for this indication; brexanolone (Zulresso), another
GABAA receptor modulator, was approved for IV
treatment of PPD in 2019.
Med Lett Drugs Ther. 2023 Dec 25;65(1692):201-3 doi:10.58347/tml.2023.1692a | Show Introduction Hide Introduction
Expanded Table: Antibiotics for Travelers' Diarrhea (online only)
The Medical Letter on Drugs and Therapeutics • Oct 07, 2019 (Issue 1582)
)
250, 500, 600 mg tabs;
100, 200 mg/5 mL PO susp
1000 mg once or divided
bid4 or 500 mg once/day
x ...
View the Expanded Table: Antibiotics for Travelers' Diarrhea
Drugs for Sexually Transmitted Infections
The Medical Letter on Drugs and Therapeutics • Jun 27, 2022 (Issue 1653)
, and rectal Chlamydia trachomatis
infections is 7 days of oral doxycycline. Oral
levofloxacin ...
This article includes recommendations for management
of most sexually transmitted infections (STIs)
other than HIV and viral hepatitis. Some of the
indications and dosages recommended here have
not been approved by the FDA (see Table 1).
Natazia - A New Oral Contraceptive
The Medical Letter on Drugs and Therapeutics • Sep 06, 2010 (Issue 1346)
combination includes an estrogen step-down and a
progestin step-up; days 1-2: estradiol valerate 3 mg
alone ...
The FDA has approved the marketing of Natazia (Bayer), a 4-phase oral contraceptive containing the
estrogen estradiol valerate and the progestin dienogest, both used for the first time in the US for this
indication.
Mifepristone (Mifeprex) Label Changes
The Medical Letter on Drugs and Therapeutics • Apr 25, 2016 (Issue 1493)
to terminate
pregnancy for up to 70 days, rather than 49 days, after
the first day of the last menstrual ...
The FDA has approved several significant changes in
the labeling of mifepristone (Mifeprex – Danco), an oral
antiprogestin that has been used in the US for more than
15 years for termination of intrauterine pregnancy. It
has generally been used with the prostaglandin analog
misoprostol (Cytotec, and generics).
Mirtazapine - A New Antidepressant
The Medical Letter on Drugs and Therapeutics • Dec 20, 1996 (Issue 990)
Dosage Cost*
Amitriptyline − generic price 200 mg once/day $ 2.57
Elavil (Zeneca) 71.61
Bupropion ...
Mirtazapine (mir taz a peen; Remeron - Organon) has been approved by the US Food and Drug Administration for treatment of depression. A tetracyclic piperazinoazepine, it is an analog of mianserin, an antidepressant available in Europe, but is structurally unrelated to antidepressants previously available in the USA.